Current status of cancer proteogenomics: a brief introduction
نویسندگان
چکیده
منابع مشابه
Review An introduction to electromagnetic field therapy and immune function: a brief history and current status
Interest in electromagnetic field (EMF) treatments has increased rapidly in recent years due to its advantages over other treatments for tissue healing and infection. Benefits include low-cost, ready availability, ease of localized application, few if any sideeffects, and indefinite shelf life. Immunological studies show that low-intensity EMF can interact with cells and tissues, providing a la...
متن کاملMethods, Tools and Current Perspectives in Proteogenomics.
With combined technological advancements in high-throughput next-generation sequencing and deep mass spectrometry-based proteomics, proteogenomics, i.e. the integrative analysis of proteomic and genomic data, has emerged as a new research field. Early efforts in the field were focused on improving protein identification using sample-specific genomic and transcriptomic sequencing data. More rece...
متن کاملneurolaw: a brief introduction.
neurolaw, as an interdisciplinary field which links the brain to law, facilitates the pathway to better understanding of human behavior in order to regulate it accurately through incorporating neuroscience achievements in legal studies. since 1990's, this emerging field, by study on human nervous system as a new dimension of legal phenomena, leads to a more precise explanation for human behavio...
متن کاملUnderground Coal Gasification: A Brief Review of Current Status
Coal gasification is a promising option for the future use of coal. Similarly to gasification in industrial reactors, underground coal gasification (UCG) produces syngas, which can be used for power generation or for the production of liquid hydrocarbon fuels and other valuable chemical products. As compared with conventional mining and surface gasification, UCG promises lower capital/operating...
متن کاملCurrent status of cancer immunotherapy
To prove clinical benefits of cancer vaccine is currently difficult, except for one phase III trial has documented improved overall survival with the vaccine, Sipuleucel-T, although induction of anti-tumor immune responses through cancer vaccine is theoretically promising and would be straightforward. In contrast, immune checkpoint blockade with anti-CTLA4 mAb and anti-PD-1 mAb has demonstrated...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Electrophoresis
سال: 2019
ISSN: 1349-9394,1349-9408
DOI: 10.2198/jelectroph.63.33